Clinical Trial Update: Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS [Phase 1, Phase 2]

View source ↗

Summary

A safety study evaluating mocetinostat in combination with azacitidine in patients with myelodysplastic syndrome completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Mocetinostat (mocetinostat)

Snippet

Sponsor: Mirati Therapeutics Inc. | Conditions: Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: COMPLETED